DNA Methyl Transferases: A novel target for Prevention and Therapy
Cancer is the second leading cause of death in US. Despite the emergence of new, targeted agents and the use of various therapeutic combinations, none of the available treatment options are curative in patients with advanced cancer. Epigenetic alterations are increasingly recognized as valuable targ...
Main Authors: | Dharmalingam eSubramaniam, Ravi eThombre, Animesh eDhar, Shrikant eAnant |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-05-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fonc.2014.00080/full |
Similar Items
-
Celastrol and Triptolide Suppress Stemness in Triple Negative Breast Cancer: Notch as a Therapeutic Target for Stem Cells
by: Prabhu Ramamoorthy, et al.
Published: (2021-04-01) -
miR-137 Regulates the Tumorigenicity of Colon Cancer Stem Cells through the Inhibition of DCLK1
by: Sakaguchi, Masazumi
Published: (2017) -
Etude du rôle de la protéine kinase DCLK3 dans les mécanismes de neurodégénérescence dans la maladie de Huntington
by: Longprez, Lucie de
Published: (2018) -
Three putative DNA methyltransferases of Verticillium dahliae differentially contribute to DNA methylation that is dispensable for growth, development and virulence
by: H. Martin Kramer, et al.
Published: (2021-05-01) -
Specific or not specific recruitment of DNMTs for DNA methylation, an epigenetic dilemma
by: Eric Hervouet, et al.
Published: (2018-02-01)